Ceapro Inc.
CRPOF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -48.9% | 9.6% | 13.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 37% | 58.5% | 56.3% | 50.4% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -39.8% | 40% | 27.5% | 26.7% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -48.9% | 23.3% | 19.6% | 12.3% |
| EPS Diluted | -0.06 | 0.056 | 0.043 | 0.024 |
| % Growth | -207.5% | 30.8% | 79.8% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |